ImmunovantInc Net Working Capital from 2010 to 2024

IMVT Stock  USD 28.32  0.11  0.39%   
ImmunovantInc Net Working Capital yearly trend continues to be comparatively stable with very little volatility. Net Working Capital will likely drop to about 288.9 M in 2024. From the period from 2010 to 2024, ImmunovantInc Net Working Capital quarterly data regression had mean square error of 13044.8 T and mean deviation of  166,861,202. View All Fundamentals
 
Net Working Capital  
First Reported
2010-12-31
Previous Quarter
415.2 M
Current Value
288.9 M
Quarterly Volatility
188.1 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check ImmunovantInc financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImmunovantInc main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 30.1 M or Other Operating Expenses of 251.5 M, as well as many exotic indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 5.79. ImmunovantInc financial statements analysis is a perfect complement when working with ImmunovantInc Valuation or Volatility modules.
  
This module can also supplement ImmunovantInc's financial leverage analysis and stock options assessment as well as various ImmunovantInc Technical models . Check out the analysis of ImmunovantInc Correlation against competitors.
For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.

Latest ImmunovantInc's Net Working Capital Growth Pattern

Below is the plot of the Net Working Capital of ImmunovantInc over the last few years. It is ImmunovantInc's Net Working Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in ImmunovantInc's overall financial position and show how it may be relating to other accounts over time.
Net Working Capital10 Years Trend
Slightly volatile
   Net Working Capital   
       Timeline  

ImmunovantInc Net Working Capital Regression Statistics

Arithmetic Mean134,471,798
Coefficient Of Variation139.90
Mean Deviation166,861,202
Median(55,448)
Standard Deviation188,122,817
Sample Variance35390.2T
Range468.5M
R-Value0.81
Mean Square Error13044.8T
R-Squared0.66
Significance0.0002
Slope34,115,367
Total Sum of Squares495462.7T

ImmunovantInc Net Working Capital History

2024288.9 M
2023415.2 M
2022361 M
2021468.4 M
2020390.2 M
201993.8 M

About ImmunovantInc Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include ImmunovantInc income statement, its balance sheet, and the statement of cash flows. ImmunovantInc investors use historical funamental indicators, such as ImmunovantInc's Net Working Capital, to determine how well the company is positioned to perform in the future. Although ImmunovantInc investors may use each financial statement separately, they are all related. The changes in ImmunovantInc's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on ImmunovantInc's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on ImmunovantInc Financial Statements. Understanding these patterns can help to make the right decision on long term investment in ImmunovantInc. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Working Capital415.2 M288.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether ImmunovantInc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if ImmunovantInc Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Immunovantinc Stock. Highlighted below are key reports to facilitate an investment decision about Immunovantinc Stock:
Check out the analysis of ImmunovantInc Correlation against competitors.
For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.
You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.

Complementary Tools for ImmunovantInc Stock analysis

When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.81)
Return On Assets
(0.27)
Return On Equity
(0.45)
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.